Sociedad Americana de Hirudoterapia

Supermicrosurgical replantation of a small amputated nasal tissue in a child

Case report published in Clin Case Rep (2017)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportEnsayos clínicosTee R et al. · Clinical case reports, 2017

Abstract

This study reports a case of an 8-year-old boy who suffered from a dog bite injury to the nose. The amputated nasal tissue measured approximately 1.0 × 1.5 cm and included part of the tip, alar, and soft triangle subunits. Both ends of an artery of less than 0.5 mm were found, and replantation was performed. Chemical leeching was performed postoperatively. At 5-year follow-up, a good aesthetic result was achieved.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article

Resumen

8-year-old boy with dog-bite nasal-tissue amputation (1.0x1.5 cm) successfully replanted via supermicrosurgical arterial anastomosis (<0.5mm) and postoperative chemical leeching. Good aesthetic outcome at 5-year follow-up.

Por qué esto importa para la hirudoterapia

This case report describes replantation of a small (approximately 1.0 × 1.5 cm) amputated nasal tissue in an 8-year-old boy after a dog bite, with arterial anastomosis of a vessel less than 0.5 mm. Chemical leeching was performed postoperatively, and a good aesthetic result was achieved at 5-year follow-up. This is relevant to ASH's domain as it documents adjunctive chemical leeching used after nasal replantation, a pharmacological approach conceptually related to, but distinct from, live leech therapy. The honest caveat is that this is a single case report, no details about the chemical leeching agent or mechanism are given, the method is non-leech rather than actual hirudotherapy, and the contribution of chemical leeching to the outcome cannot be isolated from the surgical repair.

Citación

Supermicrosurgical replantation of a small amputated nasal tissue in a child.

Tee R et al. · Clinical case reports, 2017

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.